Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Caden Lane Black Friday Sale
Fine print flips promotion on its head.
WaterAid: Unthinkable Birth
No woman should have to give birth without clean water.
Zyn Meets Adderall? TINA.org Takes Action against Ultra’s Deceptive Marketing
Why regulators need to step in and what’s at stake.
George’s Caps
Purported closing-down sale is deceiving consumers, with the help of AI.
Blissy Silk Pillowcases
Company hits snooze on promised marketing changes.